 Onconova Therapeutics, Inc. NASDAQ: ONTX shares are trading higher after Guggenheim initiated coverage on the stock with a Buy rating and 4 price target. Onconova Therapeutics is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. 